1. Scavenger Receptor B-1 Emerges as Anti-atherogenic Candidate
Scott M. Grundy 
Cell Metabolism 
Volume 23, Issue 5, Pages (May 2016)
DOI: /j.cmet
Copyright © Terms and Conditions

2. Figure 1
Reverse Cholesterol Transport from Peripheral Tissues to the Liver
Free (non-esterified) cholesterol (FC) is believed to be transferred to small HDL particles (HDL-3) by multiple mechanisms. Cholesterol in HDL-3 is esterified by lecithin-cholesterol acyl transferase (LCAT), which expands HDL particle size (HDL-2). A portion of cholesterol ester is transferred to very-low-density lipoproteins (VLDL). This transfer is mediated by cholesterol ester transfer protein (CETP). VLDL triglyceride is removed by lipolysis, which converts VLDL to low-density lipoprotein (LDL). The latter is removed by the liver through LDL receptors (LDLR). This represents one pathway of reverse cholesterol transport. A second way is through uptake of cholesterol esters from HDL-2 via scavenger receptor-B1 (SR-B1) located on liver and adrenal gland. In the liver, cholesterol ester is de-esterified and excreted in the bile (or converted to bile acids). In the adrenal gland, cholesterol is used as a precursor for synthesis of steroid hormones. Removal of cholesterol ester from HDL-2 transforms HDL back to HDL-3.
Cell Metabolism  , DOI: ( /j.cmet )
Copyright © Terms and Conditions